Discover a new way to find and share stories you'll love… Learn about Reading Desk

Post Profile



FDA delays decision on drug to prevent HIV

The Food and Drug Administration is delaying by three months a decision on whether to approve a drug for preventing infection with HIV, the virus that causes AIDS. An agency decision on the drug Truvada, made by Gilead Sciences, was expected by June 15. But the decision was pushed back to give the agency time to review a new Gilead plan to limit the risks to healthy people taking the drug, Cara Miller, a company spokeswoman, said Friday.
read more

share

Doctors To FDA: "HIV Prevention Pill" Not Ready For Approval

Health : Medical News Today (3 years ago)

Last week, a group of 55 U.S. physicians sent a letter to the U.S. Food & Drug Administration (FDA), urging the agency not to approve the use of Gilead's HIV/AIDS treatment drug Truvada for use as an HIV prevention pill - also known... Read Post

FDA Delays Decision on First Drug to Prevent HIV

Health : Healthland (2 years ago)

(WASHINGTON) — Federal health regulators have delayed a decision on whether to approve the first pill shown to prevent HIV infection, the drug’s manufacturer says. Gilead Sciences disclosed Friday that the Food and Drug Administrati... Read Post

FDA Approves First Pill to Prevent HIV: Truvada

Health : Healthland (2 years ago)

The Food and Drug Administration (FDA) on Monday approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes AIDS. The agency approved Gilead Sciences’ pill Truv... Read Post


Copyright © 2011 Regator, LLC